Feasibility, Safety and Predictors of Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia Discharged “Early” after Intensive Induction Therapy

Feasibility, Safety and Predictors of Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia Discharged “Early” after Intensive Induction Therapy

Background: Patients (pts) treated with intensive induction therapy for newly diagnosed acute myeloid leukemia (AML) traditionally remain admitted until an absolute neutrophil count (ANC) >0.5 x 10 3/L. Although a small number of centers reported on pt discharge with ANC

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2023-11, Vol.142 (Supplement 1), p.589-589
Hauptverfasser: Hunter, Cameron, Cheng, Wei, Halene, Stephanie, Mendez, Lourdes, Podoltsev, Nikolai A., Zeidan, Amer M., Barbarotta, Lisa, Shallis, Rory M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Patients (pts) treated with intensive induction therapy for newly diagnosed acute myeloid leukemia (AML) traditionally remain admitted until an absolute neutrophil count (ANC) >0.5 x 10 3/L. Although a small number of centers reported on pt discharge with ANC
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2023-182989